Yıl: 2007 Cilt: 18 Sayı: 1 Sayfa Aralığı: 59 - 71 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Bipolar bozukluk ile anksiyete bozukluğu birlikteliği: Bir gözden geçirme

Öz:
Son yıllarda artan sayıda klinik ve epidemiyolojik çalışma, bipolar bozukluk ile anksiyete bozukluklarının yüksek oranda birliktelik gösterdiklerini bildirmektedir. Bu çalışmalar bu iki hastalık grubu arasındaki birlikteliğin istisnadan çok kural niteliğinde olduğu ve anksiyete bozukluğu ek tanısının tüm topluma oranla bipolar bozukluk hastalarında daha yüksek oranda bulunduğunu göstermiştir. Bipolar bozukluk tanısı almış hastalarda yaşam boyu anksiyete bozukluğu ek tanısı görülme sıklığı % 24 ile % 93 arasında değişmektedir. Bu hastaların büyük kısmında birden fazla anksiyete bozukluğu ek tanısı bulunmaktadır. Anksiyete bozuklukları ek tanısı alan bipolar bozukluk hastalarında genel psikopatoloji düzeyinde önemli bir artışın olduğu, tedavi yanıtının azaldığı, hastalık sürecinin olumsuz etkilendiği ve özkıyım riskinin arttığı görülmüştür. Günümüzde yaygın olan tedavi uygulamalarında, bipolar bozukluğa ait belirtilerin tedavisinin çoğu zaman öncelikli olarak ele alınması, eşlik eden anksiyete bozuklukları tanısına yeterli dikkat ve özenin gösterilmesini önlemektedir. Bu durum tedavinin gecikmesine, direnç oluşmasına ve ciddi işlev yitimlerine neden olmaktadır. Bu sorunları önleyebilmek ve hastaların yaşam kalitesini artırabilmek için, anksiyete bozukluğu ek tanısının erken aşamada-gerekirse tarama testleri kullanılarak-tanınması ve tedavi edilmesi büyük önem taşımaktadır. Bu gözden geçirme yazısında, bipolar bozukluk-anksiyete bozuklukları birlikteliğine yönelik yaygınlık çalışmalarının ışığında, ek tanının sosyodemografik ve klinik değişkenlerle olan ilişkisi ve olası tedavi yaklaşımlarına değinilecektir.
Anahtar Kelime: İki uçlu duygu durum bozukluğu Kaygı bozuklukları Eş tanı

Konular: Pediatri Psikoloji Psikiyatri

Comorbid anxiety disorders in bipolar disorder patients: A review

Öz:
In recent years, a growing number of clinical and epidemiological studies have reported high rates of comorbid anxiety disorder in patients with bipolar disorder. These studies have stated that comorbid anxiety disorder in bipolar patients is the rule rather than the exception. Lifetime anxiety disorder comorbidity rates among bipolar disorder patients are estimated to be between 24% and 93%, based on several different clinical and epidemiological studies. Bipolar patients usually are diagnosed with comorbid multiple anxiety disorders rather than a single one. Anxiety disorder comorbidity is associated with greater psychopathology, decreased treatment response, poor outcome, and increased suicidality. Current prevalent treatment approaches almost always give priority to the symptomatic treatment of bipolar episodes, which inevitably influences the provision of adequate attention and care to the diagnosis and treatment of a comorbid anxiety disorder. This approach has important therapeutic and clinical implications, such as delays in treatment leading to resistance to drugs and severe functional losses. Therefore, the treating psychiatrist needs to carefully evaluate, diagnose, and treat comorbid anxiety disorders in the early stages to avoid any unpleasant consequences and to improve the quality of life of patients. In this paper, an overview of comorbid anxiety disorder in bipolar disorders is presented, with a special emphasis on its prevalence, its relationship to sociodemographic and clinical variables, and possible therapeutic approaches.
Anahtar Kelime: Comorbidity Bipolar Disorder Anxiety Disorders

Konular: Pediatri Psikoloji Psikiyatri
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • Akiskal HS (2002) Classification, diagnosis and boundaries of bipolar disorders: A review. Bipolar Disorders, 1. baskı, M Maj, HS Akiskal, JJ Lopez-Ibor, N Sartorius (Ed), West Sussex, U.K., Wiley, s. 1-52.
  • Altındağ A, Yanık M, Nebioğlu M ve ark. (2006) The comorbidity of anxiety disorders in bipolar I patients: prevalence and clinical correlates. Isr J Psychiatry Rel et Sci (baskıda).
  • Bauer MS, Altshuler L, Evans DR ve ark. (2005) Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a mult-site public sector sample with bipolar disorder. J Affect Disord, 85:301-315.
  • Boylan KR, Bieling PJ, Marriott M ve ark. (2004) Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder. J Clin Psychiatry, 65:1106-1113.
  • Bremner JD, Krystal JH, Southwick SM ve ark. (1998) Noradrenergic mechanisms in stress and anxiety: II. Clinical studies. Synapse, 23:39-51.
  • Brieger P (2000) Comorbidity in bipolar affective disorder, in Bipolar Disorders: 100 years after manic-depressive insanity (Eds: A Marneros, J Angst) Kluwer Acad, Great Britain, 215-229.
  • Bystritsky A, Ackerman DL, Rosen RM ve ark. (2004) Augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder using adjunctive olanzapine: a placebo controlled trial. J Clin Psychiatry, 65:565-568.
  • Cassano GB, Pini S, Saettoni M ve ark. (1999) Multiple anxiety disorder comorbidity in patients with mood spectrum disorders with psychotic disorders. Am J Psychiatry, 156:474-476.
  • Chen YW, Dilsaver SC (1995a) Comorbidity of panic disorder in bipolar illness: evidence from the Epidemiological Catchment Area survey. Am J Psychiatry, 152:280-282.
  • Chen YW, Dilsaver SC (1995b) Comorbidity for obsessive-compulsive disorder in bipolar and unipolar disorders. Psychiatry Res, 59:57-64.
  • Connor KM, Payne VM, Gadde KM ve ark. (2005) The use of aripiprazole in obsessive compulsive disorder: preliminary observations in 8 patients. J Clin Psychiatry, 66:49-51.
  • Cosoff SJ, Hafner RJ (1998) The prevalence of comorbid anxiety in schizophrenia, schizoaffective disorder and bipolar disorder. Aust NZJ Psychiatry, 32:67-72.
  • Denys D, van Megen H, Westenberg H ve ark. (2002) Quetiapine addition to erotonin reputake inhibitor treatment in patients with treatment-refractory obsessive-compulsive disorder: an open-label study. J Clin Psychiatry, 63:700-703.
  • Dick CL, Bland RC, Newman SC ve ark. (1994) Epidemiology of psychiatric disorders in Edmonton: Panic disorder. Acta Psychiatr Scand, 376(Suppl):36-44.
  • Dickstein DP, Rich BA, Binstock AB ve ark. (2005) Comorbid anxiety in phenotypes of pediatric bipolar disorder. J Child Adolesc Psychopharmacol, 15:534-548.
  • Doughty CJ, Wells JE, Joyce PR ve ark. (2004) Bipolar-panic disorder comorbidity within bipolar disorder families: a study of siblings. Acta Psychiatr Scand, 6:245-252.
  • Feske U, Frank E, Mallinger AG ve ark. (2000) Anxiety as a correlate of response to the acute treatment of bipolar I disorder. Am J Psychiatry, 157:956-962.
  • Fesler FA (1991) Valproate in combat-related posttraumatic stress disorder. J Clin Psychiatry, 52:361-364.
  • Forster PL, Schoenfeld FB, Marmar C ve ark. (1995) Lithium for irritability in post-traumatic stress disorder. J Trauma Stress, 8:143-149.
  • Freeman MP, Freeman SA, McElroy SL ve ark. (2002) The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues. J Affect Disord, 68:1-23.
  • Gaudiano BA, Miller IW (2005) Anxiety disorder comorbidity in Bipolar I Disorder: relationship to depression severity and treatment outcome. Depress Anxiety, 21:71-77.
  • Guay DR (1995) The emerging role of valproate in bipolar disorder and other psychiatric disorders. Pharmacotherapy, 16:631-647.
  • Hamner MB, Brodrick PS, Labbate LA ve ark. (2001) Gabapentin in PTSD: A retrospective, clinical series of adjunctive therapy. Ann Clin Psychiatry, 13:141-146.
  • Hamner MB, Deitsch SE, Brodrick PS ve ark. (2003) Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy. J Clin Psychopharmacol, 23:15?20.
  • Henry C, Van den Bulke D, Bellivier F ve ark. (2003) Anxiety disorders in 318 bipolar patients: Prevalence and impact on illness severity and response to mood stabilizer. J Clin Psychiatry, 64:331-335.
  • Himmelhoch JM (1998) Social anxiety, hypomania and the bipolar spectrum: data, theory and clinical issues. J Affect Disord, 50:203-213.
  • Issler CK, Sant?anna MK, Kapczinski F ve ark. (2004) Anxiety disorders comorbidity in bipolar disorder. Rev Bras Psiquiatr, 26(Suppl 3): 31-36.
  • Karataş G, Tamam L, Özpoyraz N ve ark. (2003) Anksiyete bozukluklarında gabapentin tedavisi. Klinik Psikofarmakoloji Bülteni, 13:37-42.
  • Keck PE, Strawn JR, McElroy SL ve ark. (2006) Pharmacologic treatment considerations in co-occurring bipolar and anxiety disorders. J Clin Psychiatry, 67(suppl 1):8?15.
  • Keller MB (2006) Prevalence and impact of comorbid anxiety and bipolar disorder. J Clin Psychiatry, 67(suppl 1):5?7.
  • Kent JM, Coplan JD, Gorman JM ve ark. (1998) Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety. Biol Psychiatry, 44:812-824.
  • Kessler RC, Rubinow DR, Holmes C ve ark. (1997) The epidemiology of DSM-III-R bipolar I disorder in a general population survey. Psychol Med, 27:1079-1089.
  • Kessler RC, DuPont RL, Berglund P ve ark. (1999) Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys. Am J Psychiatry, 156:1915-1923.
  • Krishnan KR (2005) Psychiatric and medical comorbidities of bipolar disorder. Psychosom Med, 67:1?8.
  • Krüger S, Baruning P, Cooke RG ve ark. (2000) Comorbidity of obsessive-compulsive disorder in recovered inpatients with bipolar disorder. Bipolar Disord, 2:71-74.
  • Krüger S, Cooke RG, Hasey GM ve ark. (1995) Comorbidity of obsessive compulsive disorder in bipolar disorder. J Affect Disord, 34:117-120.
  • Lipper S (1988) PTSD and carbamazepine. Am J Psychiatry, 145:1322-1323.
  • Lykouras L, Alevizos B, Michalopoulou P ve ark. (2003) Obsessivecompulsive symptoms induced by atypical antipsychotics. A review of the reported cases. Prog Neuropsychopharmacol Biol Psychiatry, 27:333-346.
  • MacKinnon DF, McMahon FJ, Simpson SG ve ark. (1997) Panic disorder with familial bipolar disorder. Biol Psychiatry, 42:829-831.
  • MacKinnon DF, Jianfeng XP, McMahon F ve ark. (1998) Bipolar disorder and panic disorder in families: an analysis of chromosome 18 data. Am J Psychiatry, 155:829-831.
  • MacKinnon DF, Zandi PP, Cooper J ve ark. (2002) Comorbid bipolar disorder and panic disorder in families with a high prevalence of bipolar disorder. Am J Psychiatry, 159:30-35.
  • Mahmood T, Silverstone T (2001) Serotonin and bipolar disorder. J Affect Disord, 66:1-11.
  • Manning JS, Haykal RF, Connor P ve ark. (1997) On the nature of depressive and anxious states in a family practice setting: the high prevalence of bipolar II and related disorders in a cohort followed longitudinally. Compr Psychiatry, 38:102-108.
  • McElroy SL, Altshuler LL, Suppes T ve ark. (2001) Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry, 158:420-426.
  • Metin O, Yazıcı K, Tot S ve ark. (2003) Amisulpiride augmentation in treatment resistant obsessive-compulsive disorder: an open trial. Hum Psychopharmacol, 18:463-467.
  • Monnelly EP, Ciraulo DA, Knapp C ve ark. (2003) Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder. J Clin Psychopharmacol, 23:193?196.
  • Mueser KT, Trumbetta SL, Rosenberg SD ve ark. (1998) Trauma and post-traumatic stress disorder in severe mental illness. J Consult Clin Psychol, 66:443-449.
  • Myers JE, Thase ME (2000) Anxiety in the patient with bipolar disorder: recognition, significance and approaches to treatment. Psychiatr Ann, 30:456-464.
  • Otto MW, Perlman CA, Wernicke R ve ark. (2004) Posttraumatic stress disorder in patients with bipolar disorder: a review of prevalence, correlates, and treatment strategies. Bipolar Disord, 6:470?479.
  • Pande AC, Davidson JR, Jefferson JW ve ark. (1999) Treatment of social phobia with gabapentin: a placebo-controlled study. J Clin Psychopharmacol, 19:341-348.
  • Perugi G, Akiskal HS, Gemignani A ve ark. (1998) Episodic course in obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci, 248:240-244.
  • Perugi G, Akiskal HS, Pfanner C ve ark. (1997) The clinical impact of bipolar and unipolar affective comorbidity on obsessive-compulsive disorder. J Affect Disord, 45:15-23.
  • Perugi G, Akiskal HS, Ramaciotti S ve ark. (1999a) Depressive comorbidity of panic, social phobic, and obsessive-compulsive disorders re-examined: Is there a bipolar II connection? Psychiatr Res, 33:53-61.
  • Perugi G, Toni C, Akiskal HS ve ark. (1999b) Anxious-bipolar comorbidity. Diagnostic and treatment challenges. Psychiatr Clin North Am, 22:565-583.
  • Perugi G, Akiskal HS, Toni C ve ark. (2001) The temporal relationship between anxiety disorders and (hypo) mania: a retrospective examination of 63 panic, soical phobic and obsessive-compulsive patients with comorbid bipolar disorder. J Affect Disord, 67:199-206.
  • Perugi G, Toni C (2004) Bipolarity presenting as anxiety disorder. Primary Psychiatry, 11:31-35.
  • Perugi G, Toni C, Frare F ve ark. (2002) Effectiveness of adjunctive gabapentin in resistant bipolar disorder: is it due to anxious-alcohol abuse comorbidity? J Clin Psychopharmacol, 22:584-591.
  • Petty F, Kramer GL, Dunnam D ve ark. (1990) Plasma GABA in mood disorders. Psychopharmacol Bull, 26:157-161.
  • Pfanner C, Marazziti D, Dell?Osso L ve ark. (2000) Risperidone augmentation in refractory obsessive compulsive disorder: An open-label study. Eur Neuropsychopharmacol, 10 (Suppl 3):349-350.
  • Pini S, Dell'Osso L, Amador XF ve ark. (2003) Awareness of illness in patients with bipolar I disorder with or without comorbid anxiety disorders. Aust N Z J Psychiatry, 37:355-361.
  • Pini S, Cassano GG, Simonini E ve ark. (1997) Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia. J Affect Disord, 42:145-153.
  • Pini S, Dell?Osso L, Mastrocinque C ve ark. (1999) Axis I comorbidity in bipolar disorder with psychotic features. Br J Psychiatry, 175:467-471.
  • Raja N, Azzoni A (2004) Clinical management of obsessive-compulsive-bipolar comorbidity: a case series. Bipolar Disord, 6:264-270.
  • Rihmer Z, Szadoczky E, Furedi J ve ark. (2001) Anxiety disorders comorbidity in bipolar I, bipolar II and unipolar major depression: results from a population-based study in Hungary. J Affect Disord, 67:175-179.
  • Rotondo A, Mazzanti C, Dell?Osso L ve ark. (2002) Catechol-o-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder. Am J Psychiatry, 2002;159:23-29.
  • Roy A, Dejong J, Ferraro T ve ark. (1991) CSF GABA in depressed patients and normal controls. Psychol Med, 21:613-618.
  • Sasson Y, Chopra M, Harrari E ve ark. (2003) Bipolar comorbidity: from diagnostic dilemmas to therapeutic challenge. Int J Neuropsychopharmacol, 6:139-144.
  • Shear K (1997) Anxiety and bipolar disorder. Stanley Center Innovations for Participants. 20 Ağustos 2005?te http://www.BPBkids.org/site/PageServer?pagename=lrn_014_2 adresinden indirildi.
  • Simon NM, Otto MW, Wisniewski SR ve ark. (2004) Anxiety disorder comorbidity in bipolar disorder patients: Data from the first 500 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Am J Psychiatry, 161:2222-2229.
  • Simon NM, Smoller JW, Fava M ve ark. (2003) Comparing anxiety disorders and anxiety-related traits in bipolar disorder and unipolar depression. J Psychiatr Res, 37:187-192.
  • Southwick SM, Krystal JH, Morgan CA ve ark. (1993) Abnormal noradrenergic function in posttraumatic stress disorder. Arch Gen Psychiatry, 50:266-274.
  • Stein MB, Kline NA, Matloff JL ve ark. (2002) Adjunctive olanzapine for SSRI resistant combat-related PTSD: a double-blind, placebo-controlled study. Am J Psychiatry, 159:1777?1779.
  • Strakowski SM, Sax KW, McElroy SL ve ark. (1998) Course of psychiatric and substance abuse syndromes co-occuring with bipolar disorder after a first psychiatric hospitalization. J Clin Psychiatry, 59:465-471.
  • Tamam L, Özpoyraz N (2002) Comorbidity of anxiety disorder among patients with bipolar I disorder in remission. Psychopathology, 35:203-209.
  • Tamam L, Özpoyraz N, Karatas G ve ark. (2004) Personality disorder comorbidity among patients with bipolar I disorder in remission. Acta Neuropsychiatrica, 16:175-180.
  • Tondo L, Burrai C, Scamonatti L ve ark. (1989) Carbamazepine in panic disorder. Am J Psychiatry, 146:265-266.
  • Üçok A, Karaveli D, Kundakçi T ve ark. (1998) Comorbidity of personality disorders with bipolar mood disorders. Compr Psychiatry, 39:72?74.
  • Ünal A (2002) Bipolar bozukluğa komorbid eksen-I ve eksen-II tanılarının araştırılması. Yayınlanmamış tıpta uzmanlık tezi. Fırat Üniv. Tıp Fakültesi Psikiyatri Anabilim Dalı, Elazığ. With bipolar disorder: a review of prevalence, correlates, and treatment strategies. Bipolar Disord, 6:470-479.
  • Wozniak J, Biederman J, Monuteaux MC ve ark. (2002) Parsing the comorbidity between bipolar disorder and anxiety disorders: a familial risk analysis. J Child Adolesc Psychopharmacol, 12:101-11.
  • Young LT, Cooke RG, Robb JC ve ark. (1993) Anxious and non-anxious bipolar disorder. J Affect Disord, 29:49-52.
  • Young LT, Warsh JJ, Kish SJ ve ark. (1994) Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder. Biol Psychiatry, 35:121-127.
APA TAMAM L (2007). Bipolar bozukluk ile anksiyete bozukluğu birlikteliği: Bir gözden geçirme. , 59 - 71.
Chicago TAMAM Lut Bipolar bozukluk ile anksiyete bozukluğu birlikteliği: Bir gözden geçirme. (2007): 59 - 71.
MLA TAMAM Lut Bipolar bozukluk ile anksiyete bozukluğu birlikteliği: Bir gözden geçirme. , 2007, ss.59 - 71.
AMA TAMAM L Bipolar bozukluk ile anksiyete bozukluğu birlikteliği: Bir gözden geçirme. . 2007; 59 - 71.
Vancouver TAMAM L Bipolar bozukluk ile anksiyete bozukluğu birlikteliği: Bir gözden geçirme. . 2007; 59 - 71.
IEEE TAMAM L "Bipolar bozukluk ile anksiyete bozukluğu birlikteliği: Bir gözden geçirme." , ss.59 - 71, 2007.
ISNAD TAMAM, Lut. "Bipolar bozukluk ile anksiyete bozukluğu birlikteliği: Bir gözden geçirme". (2007), 59-71.
APA TAMAM L (2007). Bipolar bozukluk ile anksiyete bozukluğu birlikteliği: Bir gözden geçirme. Türk Psikiyatri Dergisi, 18(1), 59 - 71.
Chicago TAMAM Lut Bipolar bozukluk ile anksiyete bozukluğu birlikteliği: Bir gözden geçirme. Türk Psikiyatri Dergisi 18, no.1 (2007): 59 - 71.
MLA TAMAM Lut Bipolar bozukluk ile anksiyete bozukluğu birlikteliği: Bir gözden geçirme. Türk Psikiyatri Dergisi, vol.18, no.1, 2007, ss.59 - 71.
AMA TAMAM L Bipolar bozukluk ile anksiyete bozukluğu birlikteliği: Bir gözden geçirme. Türk Psikiyatri Dergisi. 2007; 18(1): 59 - 71.
Vancouver TAMAM L Bipolar bozukluk ile anksiyete bozukluğu birlikteliği: Bir gözden geçirme. Türk Psikiyatri Dergisi. 2007; 18(1): 59 - 71.
IEEE TAMAM L "Bipolar bozukluk ile anksiyete bozukluğu birlikteliği: Bir gözden geçirme." Türk Psikiyatri Dergisi, 18, ss.59 - 71, 2007.
ISNAD TAMAM, Lut. "Bipolar bozukluk ile anksiyete bozukluğu birlikteliği: Bir gözden geçirme". Türk Psikiyatri Dergisi 18/1 (2007), 59-71.